UK's ABPI welcomes new members

The Association of the British Pharmaceutical Industry has announced the addition of new members to the trade association, including Daiichi Sankyo's UK subsidiary, following the merger of two Japanese firms. The membership applications were approved by the ABPI's board, which meets six times a year.

Jeremy Way, an ABPI spokesman, said: "it is a pleasure to welcome such a professional and diverse range of new members to the ABPI. I am sure all the new members will bring professionalism and expertise to the association to help us to support the activities of the industry in the UK."

Daiichi Sankyo, with its UK headquarters at Gerrards Cross, Buckinghamshire, has been created following the merger of two formerly separate companies. The firm becomes an ABPI full member, and is described by the group as "working on the development of new therapies in cardiovascular disease, cancer, metabolic disorders and infection."